About

Management

Company Overview

프로앱텍

Company name

ProAbTech Co., Ltd.

CEO

Jeong Haeng Cho

Date of Foundation

September 25th, 2017

Capital

USD 0.59 million

Address

Headquarters

#117, Business Incubator A(S8), 123 Cheomdan-gwagiro
( Oryong-dong, GIST), Buk-gu, Gwangju 61005, Republic of Korea

R&D Center (Seoul)

Hanilnovelia Tower 8th floor, 10, Magokjungang 1-ro, Gangseo-gu,
Seoul 07807, Republic of Korea

Administration Office (Seoul)

No. 1007, Ryuma Tower 10th Floor, 164, Gonghang-daero, Gangseo-gu,
Seoul 07807, Republic of Korea

Management

CEO 이미지
Jeonghaeng Cho, PhD

Chief Executive Officer

  • EPO commercialization, 2M USD export
  • First commercialization of PEG-interferon in Korea
  • Team Leader, Hankook Korus Pharm Co., Ltd.
  • PhD in Biotechnology, Chonnam National University
  • MS in Biotechnology, GIST
CTO 이미지
Inchan Kwon, PhD

Chief Technology Officer

  • Professor of Materials Science and Engineering, GIST
  • Researcher, LG Life Sciences
  • PhD in Chemical Engineering, Caltech USA
  • MS in Chemical Engineering, Seoul National University
CFO 이미지
Jonghwan Shin

Chief Financial Officer

  • CFO, Hankook Korus Pharm Co., Ltd.
  • KDB Capital
  • Korea Technology Finance Center
  • BA In Trade Studies, Kyungpook National University
CTO 이미지
Sunoh Shin, PhD

Chief Strategy Officer
Business Development and Planning

  • Deputy Chief, Public CMO for Microbial-based Vaccine
  • Senior Researcher, Chonnam National University Biopharmaceutical Research Center
  • PhD in Biochemistry, Chosun National University
CTO 이미지
Kyunghee Lee, PhD

Head of R&D

  • Project Director, Prestige BioPharma Ltd.
  • Senior Researcher, DUKE-NUS, Singapore
  • PostDoc at Wadsworth Center, USA
  • PhD in Biochemistry, Yonsei University

KOR